Adjuvant FOLFOX plus cetuximab vs FOLFOX in full RAS and BRAF wild type stage III colon cancer patients: Results from the PETACC8 trial

Affiliation auteurs!!!! Error affiliation !!!!
TitreAdjuvant FOLFOX plus cetuximab vs FOLFOX in full RAS and BRAF wild type stage III colon cancer patients: Results from the PETACC8 trial
Type de publicationJournal Article
Year of Publication2016
AuteursTaieb J., Le Malicot K., Balogoum R., Tabernero J., Mini E., Folprecht G., van Laethem J-L., Emile J-F., Mulot C., Fratte S., Levache C-B., Saban-Roche L., Thaler J., L. Petersen N, Sanchez E., Bridgewater J., Perkins G., Lepage C., Zaanan A., Laurent-Puig P.
JournalANNALS OF ONCOLOGY
Volume27
Date PublishedOCT 1
Type of ArticleMeeting Abstract
ISSN0923-7534
DOI10.1093/annonc/mdw370.10